IRIS UniCatt

Lombardi, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.344
AS - Asia 1.806
EU - Europa 1.568
SA - Sud America 434
AF - Africa 56
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.248
SG - Singapore 913
CN - Cina 431
SE - Svezia 376
BR - Brasile 373
IT - Italia 283
DE - Germania 167
FR - Francia 163
PL - Polonia 139
IE - Irlanda 100
IN - India 93
GB - Regno Unito 82
VN - Vietnam 81
FI - Finlandia 77
ID - Indonesia 70
CA - Canada 47
RU - Federazione Russa 40
HK - Hong Kong 31
JP - Giappone 29
MX - Messico 28
AR - Argentina 27
BD - Bangladesh 27
BE - Belgio 23
ES - Italia 23
NL - Olanda 22
UA - Ucraina 16
ZA - Sudafrica 16
KR - Corea 15
TR - Turchia 14
IQ - Iraq 13
PK - Pakistan 13
LT - Lituania 12
AT - Austria 11
EC - Ecuador 11
CI - Costa d'Avorio 10
IR - Iran 10
CH - Svizzera 9
JO - Giordania 9
MA - Marocco 9
VE - Venezuela 8
KE - Kenya 6
OM - Oman 6
CZ - Repubblica Ceca 5
IL - Israele 5
SA - Arabia Saudita 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PA - Panama 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DZ - Algeria 3
KG - Kirghizistan 3
LV - Lettonia 3
PE - Perù 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
JM - Giamaica 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.215
Salva come PNG Salva come JPEG
Città #
Chandler 486
Singapore 478
Ashburn 257
New York 155
Warsaw 131
Beijing 109
Dublin 97
Milan 82
Los Angeles 72
Jakarta 64
San Mateo 55
Rome 54
Hefei 51
Boston 49
Helsinki 48
Princeton 42
Marseille 41
São Paulo 39
Wilmington 36
The Dalles 35
Dallas 30
Frankfurt am Main 30
Ho Chi Minh City 28
Tokyo 28
Fairfield 27
Hong Kong 27
Ann Arbor 26
Moscow 26
Nuremberg 26
Houston 24
London 24
Munich 24
Nanjing 24
Brussels 23
Santa Clara 23
Hanoi 22
Seattle 21
Woodbridge 21
Turku 20
Brooklyn 19
Buffalo 18
Denver 18
Amsterdam 17
Chicago 17
Jacksonville 17
Pune 17
Düsseldorf 16
Atlanta 15
Cambridge 15
Kent 14
Montreal 14
Seoul 14
Augusta 13
Toronto 13
Cattolica 12
Council Bluffs 12
Lauterbourg 12
Redwood City 12
Chennai 11
Orem 11
Poplar 11
Abidjan 10
Dearborn 10
Dhaka 10
Guangzhou 10
Stockholm 10
Amman 9
Hyderabad 9
Johannesburg 9
Mexico City 9
Phoenix 9
Hangzhou 8
Mumbai 8
Ottawa 8
Roubaix 8
Andover 7
Curitiba 7
Lahore 7
Nanchang 7
Queens 7
Rio de Janeiro 7
Tianjin 7
Turin 7
Vienna 7
Belo Horizonte 6
Buenos Aires 6
Lappeenranta 6
Norwalk 6
Paris 6
Querétaro 6
Ankara 5
Bexley 5
Bologna 5
Calgary 5
Columbus 5
Guayaquil 5
Jinan 5
Kish 5
Manchester 5
Nairobi 5
Totale 3.449
Salva come PNG Salva come JPEG
Nome #
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 327
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 175
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 143
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 137
Sarilumab use in severe SARS-CoV-2 pneumonia 137
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 127
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 125
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 125
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 124
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 123
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 123
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 119
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 117
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 117
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 116
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 115
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 111
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 111
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults 109
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 108
HIV DNA Decay in a Treatment-Naive Patient Starting Dolutegravir Plus Lamivudine with Resistance Mutations to Integrase Inhibitors: A Case Report 108
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 108
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 108
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy 107
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication 104
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 104
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease 100
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 100
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 97
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA 95
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 95
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 94
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report 90
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 90
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 89
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients 87
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy 87
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 86
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors 86
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 84
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 82
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 81
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen 80
Evaluation of doravirine-based regimen population target in a large Italian clinical center 79
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 78
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic 77
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection 73
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 71
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 70
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 70
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 70
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 70
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 69
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 69
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 68
A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops 68
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 68
Quantification of total hiv dna as a marker to measure viral reservoir: Methods and potential implications for clinical practice 67
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 62
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 58
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 58
Response to BNT162b2 mRNA COVID-19 vaccine of ART-experienced people living with HIV: a prospective analysis from a single-center study in Rome, Italy 55
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy 53
Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype 46
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 45
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 28
Totale 6.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 10 9 2 12 12 34 10
2021/2022483 12 3 10 52 11 7 38 78 14 44 60 154
2022/20231.220 168 187 97 181 75 143 66 94 137 8 52 12
2023/2024684 16 147 17 65 26 138 47 15 18 28 97 70
2024/20251.350 23 18 161 54 103 71 97 74 161 120 256 212
2025/20262.008 468 92 186 475 673 114 0 0 0 0 0 0
Totale 6.323